| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in RGNX over the last quarter tilts toward buying: insiders added a net 102,603 shares worth roughly $949K.
Classified under Biotechnology (Health Care sector), RGNX's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 495.9K | - | - | |
| CEO | 338.1K | $4.43M | - | |
| Other | 206.0K | $2.00M | - | |
| Other | 205.5K | $1.99M | - | |
| CFO | 122.8K | $1.14M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 27, 2026 | Ciongoli Gregory Austin | Director | Buy | 102,603 | $9.25 | $949,381.45 | +664.9% | - | - | |
| Jul 2, 2026 | Pakola Steve80 | Chief Medical Officer | Sale+OE10b5-1 | 2,161 | $13.64 | $29,476.04 | -1.0% | -43.3% | - | |
| Jul 1, 2026 | Pakola Steve80 | Chief Medical Officer | Sale+OE | 56,333 | $12.23 | $688,755.82 | -20.9% | -43.1% | - | |
| May 11, 2026 | Pakola Steve80 | Chief Medical Officer | Sell10b5-1 | 15,309 | $11.02 | $168,705.18 | -6.2% | +3.4% | - | |
| Mar 10, 2026 | Pakola Steve80 | Chief Medical Officer | Sell10b5-1 | 5,124 | $10.35 | $53,033.40 | -2.0% | -38.1% | - | |
| Oct 9, 2025 | Simpson Curran64 | Chief Executive Officer | Sell10b5-1 | 20,811 | $12.62 | $262,634.82 | -8.8% | +25.2% | -33.7% | |
| Sep 29, 2025 | Simpson Curran64 | Chief Executive Officer | Sell10b5-1 | 7,624 | $10.03 | $76,468.72 | -3.1% | +45.2% | -24.4% | |
| Sep 10, 2025 | Simpson Curran64 | Chief Executive Officer | Sell10b5-1 | 7,734 | $10.02 | $77,494.68 | -3.1% | +32.9% | -10.6% | |
| May 12, 2025 | Mills Kenneth T.81 | Director | Sale+OE10b5-1 | 20,602 | $7.91 | $163,046.29 | -4.2% | -6.4% | +28.5% | |
| Oct 1, 2024 | Karabelas Argeris N73 | Director | Sale+OE10b5-1 | 10,000 | $10.11 | $101,052.00 | -47.0% | -29.2% | -4.3% |